Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2018, Article ID 1384029, 4 pages
Case Report

The Infection Returns: A Case of Pulmonary Sporotrichosis Relapse after Chemotherapy

1Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
2Section of Pulmonary, Critical Care, and Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

Correspondence should be addressed to Samid M. Farooqui; ude.cshuo@iuqooraf-dimas

Received 21 December 2017; Accepted 28 January 2018; Published 18 February 2018

Academic Editor: Jacques F. Meis

Copyright © 2018 Samid M. Farooqui and Houssein Youness. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Pulmonary sporotrichosis is a rare disease caused by a dimorphic fungus, Sporothrix schenckii. It is rarely found in association with malignancy. We present a case of pulmonary sporotrichosis recurrence after chemotherapy. Case Presentation. A 44-year-old man, treated for pulmonary sporotrichosis in the past, presented with dysphagia and was found to have squamous cell carcinoma of the esophagus. After undergoing chemotherapy, extensive cavitary lesions were observed on thoracic computed tomography scan. A bronchoalveolar lavage revealed the presence of Sporothrix schenckii sensu lato. Despite treatment with itraconazole, he eventually required a left pneumonectomy for progressive destructive cavitary lesions involving the left lung. Conclusion. This case highlights the importance of considering past fungal infections, albeit cured, in patients initiating immunosuppressive therapy.